The following data is part of a premarket notification filed by Siemens Healthcare Diagnostics Inc. with the FDA for Atellica Ch Enzymatic Creatinine_3 (ecre3).
Device ID | K212223 |
510k Number | K212223 |
Device Name: | Atellica CH Enzymatic Creatinine_3 (ECre3) |
Classification | Enzymatic Method, Creatinine |
Applicant | Siemens Healthcare Diagnostics Inc. 511 Benedict Avenue Tarrytown, NY 10591 |
Contact | Ian Thompson |
Correspondent | Ian Thompson Siemens Healthcare Diagnostics Inc. 511 Benedict Avenue Tarrytown, NY 10591 |
Product Code | JFY |
CFR Regulation Number | 862.1225 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 2021-07-16 |
Decision Date | 2021-11-24 |
Device Identifier | submissionNumber | Supplement |
---|---|---|
00630414301587 | K212223 | 000 |
00630414306438 | K212223 | 000 |